Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	64
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	45
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma	39
Optimal management of oligometastatic prostate cancer: current state and future directions	36
Treatments and challenges in advanced prostate cancer	34
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	31
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	29
Role of PSMA PET/CT in imaging and management of prostate cancer	28
Editorial introductions	27
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	26
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	25
Psycho-oncology interventions focusing on fatigue and sleep disturbances	23
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	23
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	20
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	20
Editorial introductions	19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	19
Editorial introductions	18
Safety of assisted reproductive techniques in gynecological cancer patients	17
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	16
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	15
New hopes in relapsed refractory primary central nervous system lymphoma	15
How to prevent human papillomavirus-related oropharyngeal cancer?	14
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	14
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	13

WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	13
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	13
Editorial introductions	13
Open questions on vorasidenib	13
Biomarkers and immunotherapy: where are we?	13
Indications and technique of minimally invasive surgery in early-stage cervical cancer	13
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12
Editorial introductions	12
Circulating tumor DNA in breast cancer: a biomarker for patient selection	12
Recent highlights and breakthroughs in immunotherapy for head and neck cancers	12
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	12
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	12
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	12
The evolving landscape of bispecific antibodies in the treatment of lung cancer	12
Recent advances in precision medicine for acute myeloid leukemia	11
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	11
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
Liquid biopsy in brain tumors: moving on, slowly	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Lung cancer screening in never smokers	10
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	10
Editorial introductions	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	10
Pathology and new insights in central nervous system lymphomas	10
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	10
Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings	9
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	9
Artificial intelligence in lung cancer: from diagnosis to therapy	9
A new comprehensive and stratified concept for supportive care in cancer patients	9
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	9
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	9
How to support parenting in patients with cancer and co-parents? From research to practice	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
Application of single-port techniques in endometrial cancer	8
Mind the target: programmed death ligand 1 in oesophagogastric cancers	8
Melanoma in adolescents and young adults: special considerations	8
Desmoid tumors: who, when and how to treat?	8
Editorial introductions	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	8
Editorial introductions	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Current role and indications of minimally invasive surgery in gynecologic oncology	8
New therapies for brain metastases: an update	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	7

Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	7
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	7
Evolving paradigms in the management of basal cell carcinoma	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer	7
Treatment of radiation-associated angiosarcoma	7
Global priorities for advancing cancer survivorship	7
Editorial introductions	7
Targeting cancer stem cell pathways for lung cancer therapy	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Potential application of artificial intelligence in cancer therapy	7
Pathologic diagnosis of lung cancer – recent developments	7
Adjuvant and neoadjuvant approaches in pancreatic cancer	7
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	7
Breast surgery after neoadjuvant therapy	7
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	6
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
How to treat localized Hodgkin lymphoma?	6
Patient-proxy agreement on health-related quality of life assessment in cancer patients	6
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	6
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	6
Precision, personalization, and quality of life for patients with lymphoma	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Achievements of international rare cancers networks and consortia in the neuro-oncology field	6
HIV-related lymphomas	6
Polyamine metabolism in prostate cancer	6
Clinical management of brain tumors in pregnancy	6
Editorial introductions	6
Cellular therapies in sarcoma and other solid tumors	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	6
Richter transformation: biological insights, diagnostic challenges and emerging therapies	6
Unclear territory: navigating metastatic nonclear cell renal cell carcinoma	6
Editorial introductions	5
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	5
How to monitor the side effects of treatments in cancer patients	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review	5
Perioperative immunotherapy in nonsmall cell lung cancer	5
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	5
Update of antibody–drug conjugates for hematological malignancies	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Thymic malignancies: role of immunotherapy and novel approaches	5
High-risk smoldering myeloma – a case for early intervention?	5
Targeting exon 20 insertion mutations in lung cancer	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
Immunotherapy of sarcomas with modified T cells	5
How to treat advanced Hodgkin lymphoma?	4
Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions	4
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma	4
Recent advances in immunotherapy for small cell lung cancer	4
Supportive care in the world: an international opinion on MASCC's perspectives	4
Epithelioid sarcoma: from SMARCB1 loss to therapeutic vulnerabilities	4
New trends in supportive care of head and neck cancers	4
Molecular genotyping in medullary thyroid cancer	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Vascular complications in patients with brain tumors	4
Future of sentinel node biopsy in ovarian cancer	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Early Detection of Cancers in the Era of Precision Oncology	4
Editorial introductions	4
Treatment of lung cancer in pregnant women	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Use of staging for sex cord stromal tumours	3
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	3
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists	3
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	3
New treatments for desmoid tumors	3
Advances in the treatment of light chain amyloidosis	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
New targeted treatments for advanced sarcomas	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3

The role of next-generation sequencing in acute myeloid leukemia	3
Action against thoracic cancers: recent achievements and perspectives	3
Advance care planning in oncology: a scoping review and some recommendations	3
Editorial introductions	3
Editorial: Psychological interventions in oncology: advances and challenges	3
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	3
New strategies for the treatment of breast cancer with leptomeningeal metastasis	3
Challenges in the management of relapsed germ cell tumors	3
CIC-DUX4 sarcomas	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Emerging therapies in Ewing sarcoma	3
Editorial: Advanced care planning	3
New treatment strategies for primary central nervous system lymphoma	3
Cancer-associated thrombosis: what is new?	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Editorial introductions	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Targeting androgen receptors in patients with metastatic breast cancer	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Circulating tumor DNA in B cell lymphomas	3
Evolving systemic management of urothelial cancers	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Editorial Introductions	3
New targeted therapies in liposarcoma: state of art and future perspectives	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
Treatment approaches for older Hodgkin lymphoma patients	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Reirradiation in recurrent glioblastoma	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
Management of epilepsy in brain tumor patients	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	2
Liquid biopsy in breast cancer: promises and challenges	2
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	2
Mantle cell lymphoma: how to clarify the confusion around first-line treatment?	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
The role of menin inhibitors in acute myeloid leukemia	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Interventions for children of parents with cancer: an overview	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
First line treatments in primary central nervous system lymphomas in young patients	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
Medical treatment of angiosarcomas	2
Beyond the usual – Atypical imaging presentation in lung cancer and implications for TNM-staging	2
Circulating tumor DNA in early-stage triple-negative breast cancer: clinical landscape and key open challenges	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Recent developments and outstanding challenges in germ cell tumors	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Immuno-oncology in the daily practice	2
Editorial introductions	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Sarculator: how to improve further prognostication of all sarcomas	2
Circulating tumor DNA for human papilloma virus-positive disease: ready for prime time?	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Novel therapeutics in refractory germ cell tumors	2
Chimeric antigen receptor T-cell therapy for multiple myeloma	2
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decades	2